Johnson Matthey’s (JMAT) Neutral Rating Reiterated at UBS Group

Johnson Matthey (LON:JMAT)‘s stock had its “neutral” rating reissued by equities research analysts at UBS Group in a research report issued to clients and investors on Friday,Digital Look reports. They currently have a GBX 2,200 price target on the stock. UBS Group’s target price points to a potential upside of 0.73% from the company’s previous close.

A number of other equities analysts have also recently issued reports on JMAT. Berenberg Bank cut their price target on Johnson Matthey from GBX 2,250 to GBX 2,100 and set a “buy” rating on the stock in a report on Monday, March 23rd. Deutsche Bank Aktiengesellschaft raised their price target on shares of Johnson Matthey from GBX 1,922 to GBX 2,120 and gave the stock a “buy” rating in a report on Tuesday, April 7th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of GBX 2,218.33.

Johnson Matthey Stock Performance

Shares of JMAT opened at GBX 2,184 on Friday. The firm’s fifty day simple moving average is GBX 2,000.77 and its two-hundred day simple moving average is GBX 2,105.43. Johnson Matthey has a 12 month low of GBX 1,660 and a 12 month high of GBX 2,434. The company has a current ratio of 1.65, a quick ratio of 0.76 and a debt-to-equity ratio of 71.01. The stock has a market capitalization of £3.66 billion, a P/E ratio of -33.14, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.91.

Insider Buying and Selling at Johnson Matthey

In related news, insider Andrew Cosslett acquired 5,136 shares of the firm’s stock in a transaction on Tuesday, February 24th. The stock was purchased at an average cost of GBX 1,937 per share, with a total value of £99,484.32. Also, insider Liam Condon acquired 5,226 shares of the stock in a transaction dated Monday, February 23rd. The stock was bought at an average cost of GBX 1,923 per share, with a total value of £100,495.98. In the last quarter, insiders purchased 10,434 shares of company stock worth $20,144,228. Insiders own 0.51% of the company’s stock.

Johnson Matthey Company Profile

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.